Challenges of Mood Disorders Care
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and by topic. Articles from the bibliography that are reprinted in this issue are in bold type.
: Treatments for the prevention and management of suicide: a systematic review. Ann Intern Med 2019; 171:334–342Crossref, Google Scholar
: Pharmacological interventions for treatment-resistant depression in adults. Cochrane Database Syst Rev 2019; 12:CD010557Google Scholar
: Benefits of sequentially adding cognitive-behavioral therapy or antidepressant medication for adults with nonremitting depression. Am J Psychiatry 2019; 176:275–286Crossref, Google Scholar
Furukawa TA, Cipriani A, Cowen PJ, et al: Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry 2019; 6:601–609Google Scholar
: Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: a large, patient- and rater-blinded, randomized, controlled study. J Psychiatr Res 2019; 111:59–67Crossref, Google Scholar
: Working with patients who self-injure. JAMA Psychiatry 2019; 76:976–977Crossref, Google Scholar
Kraus C, Kadriu B, Lanzenberger R, et al: Prognosis and improved outcomes in major depression: a review. Transl Psychiatry 2019; 9:127Google Scholar
: Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ 2019; 364:11079Google Scholar
: Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression–TRANSFORM-3. Am J Geriatr Psychiatry 2020; 28:121–141Crossref, Google Scholar
: A key differential diagnosis for physicians-major depression or burnout? JAMA Psychiatry 2019Crossref, Google Scholar
Phillips JL, Norris S, Talbot J, et al: Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial. Am J Psychiatry 2019; 176:401–409Google Scholar
: Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry 2019; 176:428–438Crossref, Google Scholar
: Difficult-to-treat depression: a clinical and research roadmap for when remission is elusive. Aust N Z J Psychiatry 2019; 53:109–118Crossref, Google Scholar
: General predictors and moderators of depression remission: a VAST-D Report. Am J Psychiatry 2019; 176:348–357Crossref, Google Scholar
: Mobile apps for mood tracking: an analysis of features and user reviews. AMIA Annu Symp Proc 2018; 2017:495–504Google Scholar
: Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cogn Behav Ther 2018; 47:1–18Crossref, Google Scholar
: Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 2018; 391:1357–1366Crossref, Google Scholar
: Physical exercise for late-life depression: effects on symptom dimensions and time course. J Affect Disord 2018; 230:65–70Crossref, Google Scholar
Rush AJ, Thase ME: Improving depression outcome by patient-centered medical management. Am J Psychiatry 2018; 175:1187–1198Google Scholar
: Prediction of response to drug therapy in psychiatric disorders. Open Biol 2018; 8:180031Crossref, Google Scholar
: Psychiatric genomics: an update and an agenda. Am J Psychiatry 2018; 175:15–27Crossref, Google Scholar
: Improving the efficiency of psychotherapy for depression: computer-assisted versus standard CBT. Am J Psychiatry 2018; 175:242–250Crossref, Google Scholar
: The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry 2018; 175:150–158Crossref, Google Scholar
: Attenuation of antidepressant effects of ketamine by opioid receptor antagonism. Am J Psychiatry 2018; 175:1205–1215
: Clinical implementation of pharmacogenetic decision support tools for antidepressant drug prescribing. Am J Psychiatry 2018; 175:873–886Crossref, Google Scholar
: Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder. Am J Psychiatry 2017; 174:533–545Crossref, Google Scholar
: Defining biotypes for depression and anxiety based on large-scale circuit dysfunction: a theoretical review of the evidence and future directions for clinical translation. Depress Anxiety 2017; 34:9–24Crossref, Google Scholar
: Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Int J Neuropsychopharmacol 2015; 19:pyv076Crossref, Google Scholar
: National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry 2010; 67:26–36Crossref, Google Scholar
: Clinical or gimmickal: the use and effectiveness of mobile mental health apps for treating anxiety and depression. Aust N Z J Psychiatry 2020; 54:20–28Crossref, Google Scholar
: Towards a consensus around standards for smartphone apps and digital mental health. World Psychiatry 2019; 18:97–98Crossref, Google Scholar
: Computer-assisted cognitive-behavior therapy and mobile apps for depression and anxiety. Curr Psychiatry Rep 2019; 21:62Crossref, Google Scholar
: Computer-assisted cognitive-behavior therapy for depression: a systematic review and meta-analysis. J Clin Psychiatry 2019; 80:18r12188Crossref, Google Scholar
: Risk factors proximate to suicide and suicide risk assessment in the context of denied suicide ideation. Suicide Life Threat Behav 2018; 48:340–352Crossref, Google Scholar
: Recent developments in the use of smartphone interventions for mental health. Curr Opin Psychiatry 2018; 31:379–388Crossref, Google Scholar
: The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 2017; 16:287–298Crossref, Google Scholar
: Biomarkers of suicide attempt behavior: towards a biological model of risk. Curr Psychiatry Rep 2017; 19:31Crossref, Google Scholar
: Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry 2016; 3:646–659Crossref, Google Scholar
: Computer-assisted cognitive-behavior therapy for depression. Psychotherapy 2014; 51:191–197Crossref, Google Scholar
: A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 1989; 57:414–419Crossref, Google Scholar
: Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. Lancet Psychiatry 2017; 4:477–485Crossref, Google Scholar
: Replication of epigenetic postpartum depression biomarkers and variation with hormone levels. Neuropsychopharmacology 2016; 41:1648–1658Crossref, Google Scholar
: Are symptom features of depression during pregnancy, the postpartum period and outside the peripartum period distinct? Results from a nationally representative sample using item response theory (IRT). Depress Anxiety 2015; 32:129–140Crossref, Google Scholar
: GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 2008; 59:207–213Crossref, Google Scholar
: Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000; 157:924–930Crossref, Google Scholar
: Reconciling suicides with “accidental” drug-intoxication deaths: a behaviorally based definition of self-injury mortality. Am J Public Health 2020; 110:73–74Crossref, Google Scholar
: Understanding links among opioid use, overdose, and suicide. N Engl J Med 2019; 380:71–79Crossref, Google Scholar
: Deciphering suicide and other manners of death associated with drug intoxication: a Centers for Disease Control and Prevention consultation meeting summary. Am J Public Health 2017; 107:1233–1239Crossref, Google Scholar
: A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain. Med Care 2016; 54:435–441Crossref, Google Scholar
: Medication-assisted therapies—tackling the opioid-overdose epidemic. N Engl J Med 2014; 370:2063–2066Crossref, Google Scholar
: Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend 2004; 76(Suppl):S11–S19Crossref, Google Scholar
: A new initiative on precision medicine. N Engl J Med 2015; 372:793–795Crossref, Google Scholar
: The digital phenotype. Nat Biotechnol 2015; 33:462–463Crossref, Google Scholar
: The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Per Med 2011; 8:161–173Crossref, Google Scholar
: Ecological momentary assessment. Annu Rev Clin Psychol 2008; 4:1–32Crossref, Google Scholar
: Biomarkers in psychiatry. Nature 2009; 460:202–207Crossref, Google Scholar
: A further look at therapeutic interventions for suicide attempts and self-harm in adolescents: an updated systematic review of randomized controlled trials. Front Psychiatry 2018; 9:583Crossref, Google Scholar
: Concomitant use of atypical antipsychotics with other psychotropic medication classes and the risk of type 2 diabetes mellitus. J Am Acad Child Adolesc Psychiatry 2017; 56:642–651Crossref, Google Scholar
: Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009; 302:1765–1773Crossref, Google Scholar
